DCF — NEVADA REGIONAL MEDICAL CENTER
Enterprise Value: $-87.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-87.0M
Enterprise Value
$-27.2M
PV of Cash Flows
$-59.8M
PV of Terminal Value
$-96.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $43.8M | $-5.6M | -13.0% | $-7.5M | $-6.8M |
| Year 2 | $45.1M | $-5.3M | -12.0% | $-7.2M | $-6.0M |
| Year 3 | $46.4M | $-5.0M | -11.0% | $-7.0M | $-5.3M |
| Year 4 | $47.8M | $-4.9M | -10.0% | $-7.0M | $-4.8M |
| Year 5 | $49.3M | $-5.0M | -10.0% | $-7.1M | $-4.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-87.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$42.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.13334259636937162
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5